Accumulated evidence demonstrates that adult T-cell leukemia (ATL) is frequently associated with eosinophilia, and human T-lymphotropic virus type 1 (HTLV-1)-infected cells frequently express interleukin-5 (IL-5).However, the molecular mechanism of constitutive IL-5 expression in HTLV-1-infected cells remains unclear. To clarify the mechanism of aberrant IL-5 expression in HTLV-1-infected cells, we investigated the response of the human IL-5 promoter to the HTLV-1-encoded protein Tax. Cotransfection experiments using Jurkat cells revealed that Tax is incapable of activating the IL-5 promoter by itself but that it synergistically transactivates the promoter with GATA-binding protein (GATA-4) and 12-O-tetradecanoylphorbol-13-acetate (TPA) stimulation. By introducing a series of mutations within the IL-5 promoter, we found that conserved lymphokine element 0 (CLE0) is responsible for mediating the signal induced by Tax-TPA. A deletion construct of the promoter indicated that the ؊75 GATA element and CLE0 are sufficient to mediate synergistic activation of the IL-5 promoter. Electrophoretic mobility shift assays using Jurkat cell nuclear extracts demonstrated that TPA induces a transcription factor to bind CLE0, and an experiment using JPX-9 cell nuclear extracts showed that Tax Human interleukin-5 (IL-5) is a cytokine produced by activated T lymphocytes and stimulates growth and differentiation of eosinophils (55). An increase in the number of eosinophils (i.e., eosinophilia) is clinically observed in patients with diseases such as idiopathic eosinophilia, asthma, Hodgkin's disease, and parasite infections. In these patients, significant levels of IL-5 in the serum or IL-5 mRNA in tissues are detected (17,29,44,54,55), and thus the high level of IL-5 expression is strongly linked to eosinophilia in a wide variety of diseases. Findings from studies of IL-5 transgenic mice have indicated the central role of IL-5 in eosinophilia (11, 37) and have shown that the high level of IL-5 expression leads to eosinophilia in vivo.Adult T-cell leukemia (ATL) is an aggressive and fatal T-cell malignancy that is caused by human T-cell lymphotropic virus type 1 (HTLV-1) infection (46,69,80). ATL is characterized by unique clinical features including rapidly developing cutaneous lesions and/or hypercalcemia (57). Eosinophilia, though not as frequently observed as the two major clinical features, is detected in patients with ATL (36,72,73,79). In a study done by Murata et al., eosinophilia was detected in up to 21% of the patients suffering from ATL (36). On the other hand, a study of ATL-derived cell lines revealed that IL-5 mRNA was expressed in 50% of the ATL cell lines surveyed (41). Therefore, the aberrant increase in the level of serum IL-5 secreted from ATL cells could be speculated to the main cause of eosinophilia in ATL patients.Tax protein is the HTLV-1-encoded protein that regulates not only HTLV-1 replication at the transcriptional level (13) but also the expression of cellular genes encoding cytokines and their recepto...